JFL Life Sciences Limited, headquartered in Ahmedabad, Gujarat, is a public pharmaceutical company that manufactures and markets a range of products including dry powder injections, B-Lactam tablets and capsules, general tablets and capsules, and Oral Rehydration Solutions (ORS). Established in April 2010 and converted to a public limited company in March 2022, JFL has a significant market presence across India and exports to 10 countries, including African, Middle Eastern, and CIS regions. The company emphasizes R&D and operates a state-of-the-art FDA-approved facility.
In August 2022, JFL Life Sciences raised Rs. 18.16 crore through an IPO of 2,978,000 equity shares. The company is registered with the Ministry of Health in various countries for specific products and exports primarily through merchant exporters. Their manufacturing process includes stringent quality assurance measures, ensuring product integrity across all stages, from granulation to final packaging.
